AZN icon

AstraZeneca

1,391 hedge funds and large institutions have $45.2B invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with 256 funds opening new positions, 497 increasing their positions, 410 reducing their positions, and 119 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,391
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$597M
Puts
$420M
Net Calls
Net Calls Change

Top Buyers

1 +$420M
2 +$412M
3 +$327M
4
Citigroup
Citigroup
New York
+$204M
5
Barclays
Barclays
United Kingdom
+$180M

Top Sellers

1 -$924M
2 -$831M
3 -$550M
4
Primecap Management
Primecap Management
California
-$258M
5
Citadel Advisors
Citadel Advisors
Florida
-$241M
Name Holding Trade Value Shares
Change
Change in
Stake
SP
1451
Saranac Partners
LCGC
1452
Legacy Capital Group California
California
PVI
1453
Pine Valley Investments
New Jersey
BBW
1454
Blue Barn Wealth
Utah
GAG
1455
GM Advisory Group
New York
CPRC
1456
Consolidated Portfolio Review Corp
New York
NP
1457
NorthRock Partners
Minnesota
JG
1458
Jain Global
New York
APA
1459
Astoria Portfolio Advisors
New York
AP
1460
Advisors Preferred
Maryland
BAM
1461
Blueshift Asset Management
New Jersey
SA
1462
Sonoma Allocations
California
MFG
1463
MidWestOne Financial Group
Iowa
SB
1464
SIG Brokerage
New York
BFA
1465
Beaumont Financial Advisors
Massachusetts
NEPPG
1466
New England Professional Planning Group
Rhode Island
BCM
1467
Bayesian Capital Management
New York
AO
1468
Advisor OS
Illinois
AGA
1469
Accuvest Global Advisors
Utah
FMWA
1470
Forvis Mazars Wealth Advisors
Missouri
MM
1471
MQS Management
New York
FNBT
1472
FineMark National Bank & Trust
Florida
FFA
1473
Founders Financial Alliance
North Carolina
DCM
1474
Donaldson Capital Management
Indiana
VF
1475
Virtu Financial
New York